31 Mar 2019
Assets187.51
Total Income206.80
EBITDA34.30
Profit After Tax20.54
NET Worth79.70
Reserves and Surplus71.67
Total Borrowing77.15
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Revenue306.29₹ Cr · +15.7% vs prior year
EBITDA71.64₹ Cr · +27.2% vs prior year
PAT52.26₹ Cr · +38.3% vs prior year
Assets314.80₹ Cr · +26.5% vs prior year
Net Worth165.96₹ Cr · +41.0% vs prior year
Borrowing90.25₹ Cr · -0.5% vs prior year
3-year financial trendRevenue / EBITDA / PAT
₹ crore31 Mar 2020
Assets248.94
Total Income264.62
EBITDA56.34
Profit After Tax37.79
NET Worth117.69
Reserves and Surplus109.66
Total Borrowing90.69
31 Mar 2021
Assets314.80
Total Income306.29
EBITDA71.64
Profit After Tax52.26
NET Worth165.96
Reserves and Surplus145.88
Total Borrowing90.25
IPO UPDATE ALERTS
Register for IPO Updates →Track Tatva Chintan Pharma without missing an update
Register for subscription, GMP, allotment and listing notifications.